Dabigatran etexilate Completed Phase 4 Trials for Prevention of Venous Thromboembolism / Moderate Renal Impairment (CrCl 30-50 mL/Min) / Arthroplasty, Replacement Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01184989Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate